Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,152 | -10,384 | -6,089 | -29,247 | -22,673 |
| Depreciation Amortization | 1,509 | 890 | 443 | 2,023 | 1,234 |
| Accounts receivable | -629 | -1,952 | -848 | -246 | -603 |
| Other Working Capital | -3,135 | -4,439 | -1,674 | 2,649 | 2,287 |
| Other Operating Activity | 3,320 | 6,261 | 3,338 | 3,165 | 4,507 |
| Operating Cash Flow | $-12,087 | $-9,624 | $-4,830 | $-21,655 | $-15,248 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -215 | -63 | -45 | -538 | -443 |
| Purchase Sale Intangibles | -330 | -183 | -82 | -398 | -358 |
| Other Investing Activity | -330 | -183 | -82 | -398 | -358 |
| Investing Cash Flow | $-545 | $-246 | $-127 | $-936 | $-800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 15,000 | N/A | N/A | 0 |
| Debt Repayment | -5,000 | -5,000 | -625 | N/A | 0 |
| Common Stock Issued | N/A | N/A | 53 | 218 | 213 |
| Other Financing Activity | -836 | -737 | 0 | 14,256 | 2,050 |
| Financing Cash Flow | $9,164 | $9,263 | $-572 | $14,474 | $2,264 |
| Exchange Rate Effect | 21 | -64 | 6 | -100 | -1 |
| Beginning Cash Position | 15,615 | 15,615 | 15,615 | 23,832 | 23,832 |
| End Cash Position | 12,168 | 14,944 | 10,092 | 15,615 | 10,047 |
| Net Cash Flow | $-3,447 | $-671 | $-5,523 | $-8,217 | $-13,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,087 | -9,624 | -4,830 | -21,655 | -15,248 |
| Capital Expenditure | -215 | -63 | -45 | -538 | -443 |
| Free Cash Flow | -12,302 | -9,687 | -4,875 | -22,193 | -15,690 |